HLB bioStep Co.,Ltd. (KOSDAQ:278650)

HLB bioStep Revenue

HLB bioStep had revenue of 15.97B KRW in the quarter ending June 30, 2026, a decrease of -10.17%. This brings the company's total for the last twelve months to 72.15B, up 9.27% year-over-year. In the year 2025, HLB bioStep had annual revenue of 74.05B with 27.30% growth. That makes HLB bioStep the 27,321st largest company in the world by revenue and 1,654th in South Korea.

• Revenue (ttm): 72.15B
• Revenue Growth: +9.27%
• P/S Ratio: 1.56
• Revenue / Employee: 511.71M
• Employees: 141
• Market Cap: 112.35B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Ministry of Bioinfrastructure 37.86B 51.1%
• Non-Clinical CRO Sector 23.19B 31.3%
• Pet Medical Sector 13.00B 17.6%

Fiscal year ended Dec 31, 2025 See the full HLB bioStep breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	74.05B	15.88B	27.30%
Dec 31, 2024	58.17B	5.35B	10.14%
Dec 31, 2023	52.81B	-33.46B	-38.79%
Dec 31, 2022	86.28B	21.87B	33.96%
Dec 31, 2021	64.40B	5.88B	10.05%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error